PATENT CLAIM ANALYSIS

Application Number: 15934596
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "093210"]

Abstract:
The present invention is relevant to the generation of multi-specific antibodies, antibodies that are distinguished by their ability to bind to multiple antigens with specificity and with affinity. In particular, the present invention is related to bi-specific antibodies.

Claim (Index 18):
The method of  claim 17  wherein the manufacturing host is selected from a member of the group consisting of 3T3 mouse fibroblast cells; BHK21 Syrian hamster fibroblast cells; MDCK, dog epithelial cells; Hela human epithelial cells; PtK1 rat kangaroo epithelial cells; SP2/0 mouse plasma cells; and NS0 mouse plasma cells; HEK 293 human embryonic kidney cells; COS monkey kidney cells; CHO, Chinese hamster ovary cells; R1 mouse embryonic cells; E14.1 mouse embryonic cells; H1 human embryonic cells; H9 human embryonic cells; PER C.6, human embryonic cells;  S. cerevisiae  yeast cells; and pichia yeast cells.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14399617', '15593721', '13298559', '15751169', '13826126']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7742280198438161
- 35 USC 102 Novelty (BERT): 0.5553316805615981
- Combined Prediction Score: 0.7523383859155943
- Mean Citation Score: 275.173576
- Max Citation Score: 422.22406
- Similarity Product: 386.3737803932178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test